IL17A and non-small cell lung carcinoma: In this context, Chen et al. recently reported that the numbers of circulating Th17 cells and serum levels of IL-17A were significantly higher in patients with NSCLC relative to those of healthy control subjects and correlated with disease type (squamous cell carcinoma vs adenocarcinoma) and stage (Chen et al., 2020).